Skip to main content
Top
Published in: Current Treatment Options in Cardiovascular Medicine 12/2014

01-12-2014 | Prevention (L Sperling and D Gaita, Section Editors)

Second-hand Smoking and CV Risk

Authors: Ioana Munteanu, MD, Florin Dumitru Mihălţan, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 12/2014

Login to get access

Opinion statement

Issues related to passive smoking have recently been addressed in the specialty literature, and they are particularly relevant from two perspectives: the effects on health and implications in the initiation of smoking among youth. The mechanisms by which tobacco smoke is involved in the pathology of heart disease are numerous, and are based not on a single action, but involve multiple factors. The effects of "second-hand" smoking on the cardiovascular system are evident in cardiovascular disease biomarkers seen in nonsmokers and the increased risk of mortality. In 2003, the World Health Assembly adopted the Framework Convention on Tobacco Control (FCTC), which was negotiated under the auspices of the World Health Organization (WHO) and is an evidence-based treaty promulgated with the intent of implementing effective policies for tobacco control. The effects of such policies have been documented in numerous studies. For example, the number of ER patients presenting with acute coronary events (myocardial infarction) has decreased 27-40 % in the U.S., 13 % in Italy, and 17 % in Scotland. The harmful consequences of passive smoking in cardiovascular and other organ systems must be confronted across the medical community. Cardiologists should unite with other specialists to encourage concerted legal action, economic measures, and public education as we work toward the tobacco endgame.
Literature
1.••
3.
go back to reference The health consequences of involuntary smoking: a report of the Surgeon General. US Department of Health and Human Services (USDHHS) 1986; DHHS Publication No. (CDC) 87–8398. The health consequences of involuntary smoking: a report of the Surgeon General. US Department of Health and Human Services (USDHHS) 1986; DHHS Publication No. (CDC) 87–8398.
4.
go back to reference Samet JM, Neta GI, Wang SS. Secondhand smoke. In: Lippmann M, editor. Environmental toxicants: human exposures and their health effects. 3rd ed. Hoboken: John Wiley & Sons, Inc; 2009. p. 709. Samet JM, Neta GI, Wang SS. Secondhand smoke. In: Lippmann M, editor. Environmental toxicants: human exposures and their health effects. 3rd ed. Hoboken: John Wiley & Sons, Inc; 2009. p. 709.
5.
go back to reference International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. 1986. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. 1986.
6.
go back to reference National Research Council (NRC), Committee on Passive Smoking. Environmental tobacco smoke: measuring exposures and assessing health effects. 1986. National Research Council (NRC), Committee on Passive Smoking. Environmental tobacco smoke: measuring exposures and assessing health effects. 1986.
7.
go back to reference Owing JH (ed). Focus on Smoking and Health Research.Hauppauge, NY: Nova Science, 2005 p 21. Owing JH (ed). Focus on Smoking and Health Research.Hauppauge, NY: Nova Science, 2005 p 21.
8.
go back to reference Glantz SA, Parmley WW. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation. 1991;83:1–12.PubMedCrossRef Glantz SA, Parmley WW. Passive smoking and heart disease: epidemiology, physiology, and biochemistry. Circulation. 1991;83:1–12.PubMedCrossRef
9.
go back to reference Glantz S, Parmley W. Passive smoking and heart disease: mechanisms and risk. JAMA. 1995;273:1047–53.PubMedCrossRef Glantz S, Parmley W. Passive smoking and heart disease: mechanisms and risk. JAMA. 1995;273:1047–53.PubMedCrossRef
10.
11.
go back to reference He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease: a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920–6.PubMedCrossRef He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease: a meta-analysis of epidemiologic studies. N Engl J Med. 1999;340:920–6.PubMedCrossRef
12.
go back to reference Thun M, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect. 1999;107 suppl 6:841–6.PubMedCrossRefPubMedCentral Thun M, Henley J, Apicella L. Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking. Environ Health Perspect. 1999;107 suppl 6:841–6.PubMedCrossRefPubMedCentral
13.
go back to reference Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684–98.PubMedCrossRef Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684–98.PubMedCrossRef
14.
go back to reference Burghuber OC, Punzengruber C, Sinzinger H, Haber P, Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986;90:34–8.PubMedCrossRef Burghuber OC, Punzengruber C, Sinzinger H, Haber P, Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986;90:34–8.PubMedCrossRef
15.
go back to reference Iso H, Shimamoto T, Sato S, Koike K, Iida M, Komachi Y. Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol. 1996;144:1151–4.PubMedCrossRef Iso H, Shimamoto T, Sato S, Koike K, Iida M, Komachi Y. Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol. 1996;144:1151–4.PubMedCrossRef
16.
go back to reference Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104:1905–10.PubMedCrossRef Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104:1905–10.PubMedCrossRef
17.
go back to reference Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, et al. Antioxidant diet preserves endothelium-dependent vasodilation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke. J Cardiovasc Pharmacol. 1998;31:649–53.PubMedCrossRef Schwarzacher SP, Hutchison S, Chou TM, Sun YP, Zhu BQ, Chatterjee K, et al. Antioxidant diet preserves endothelium-dependent vasodilation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke. J Cardiovasc Pharmacol. 1998;31:649–53.PubMedCrossRef
18.
go back to reference Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2004;24:1031–6.PubMedCrossRef Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2004;24:1031–6.PubMedCrossRef
19.
go back to reference Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997;95:31–8.PubMedCrossRef Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997;95:31–8.PubMedCrossRef
20.
go back to reference Howard G, Burke GL, Szklo M, Tell G, Eckfeldt J, Evans G, et al. Active and passive smoking and are associated with increased carotid artery wall thickness: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277–82.PubMedCrossRef Howard G, Burke GL, Szklo M, Tell G, Eckfeldt J, Evans G, et al. Active and passive smoking and are associated with increased carotid artery wall thickness: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;154:1277–82.PubMedCrossRef
21.
go back to reference Mizoue T, Ueda R, Hino Y, Yoshimura T. Workplace exposure to environmental tobacco smoke and high density lipoprotein cholesterol among nonsmokers. Am J Epidemiol. 1999;150:1068–72.PubMedCrossRef Mizoue T, Ueda R, Hino Y, Yoshimura T. Workplace exposure to environmental tobacco smoke and high density lipoprotein cholesterol among nonsmokers. Am J Epidemiol. 1999;150:1068–72.PubMedCrossRef
22.
go back to reference Moffatt RJ, Chelland SA, Pecott DL, Stamford BA. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med. 2004;38:637–41.PubMedCrossRef Moffatt RJ, Chelland SA, Pecott DL, Stamford BA. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med. 2004;38:637–41.PubMedCrossRef
23.
go back to reference Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med. 2012;186(1):11–6.PubMedCrossRef Van Eeden S, Leipsic J, Paul Man SF, Sin DD. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med. 2012;186(1):11–6.PubMedCrossRef
25.
go back to reference Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, McLean BK, Peragallo-Dittko V, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 2003;14:335–48.PubMedCrossRef Kendall DM, Sobel BE, Coulston AM, Peters Harmel AL, McLean BK, Peragallo-Dittko V, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 2003;14:335–48.PubMedCrossRef
26.
go back to reference Prignot JJ. Recent contributions of air- and biomarkers to the control of secondhand smoke (SHS): a review. Int J Environ Res Public Health. 2011;8:648–82.PubMedCrossRefPubMedCentral Prignot JJ. Recent contributions of air- and biomarkers to the control of secondhand smoke (SHS): a review. Int J Environ Res Public Health. 2011;8:648–82.PubMedCrossRefPubMedCentral
27.
go back to reference U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general; department of health and human services, centers for disease control and prevention, national center for chronic disease prevention and health promotion, office on smoking and health: Atlanta, GA, USA, 2006. U.S. Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: a report of the surgeon general; department of health and human services, centers for disease control and prevention, national center for chronic disease prevention and health promotion, office on smoking and health: Atlanta, GA, USA, 2006.
28.
go back to reference Directive 2000/69/EC of the European Parliament and of the Council of 16 November 2000. Relating to limit values for benzene and carbon monoxide in ambient air. Off J Eur Commun. 2000. L313, 12–20. Directive 2000/69/EC of the European Parliament and of the Council of 16 November 2000. Relating to limit values for benzene and carbon monoxide in ambient air. Off J Eur Commun. 2000. L313, 12–20.
29.
go back to reference Bernert Jr JT, McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol. 2000;24:333–9.PubMedCrossRef Bernert Jr JT, McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal Toxicol. 2000;24:333–9.PubMedCrossRef
30.
go back to reference Pitsavos C et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11:220–5.PubMedCrossRefPubMedCentral Pitsavos C et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11:220–5.PubMedCrossRefPubMedCentral
31.
go back to reference Engström G. Lung function and cardiovascular risk relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555–60.PubMedCrossRef Engström G. Lung function and cardiovascular risk relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555–60.PubMedCrossRef
32.••
go back to reference Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2010;14(4):CD005992. doi:10.1002/14651858.CD005992.pub2. This is a general review of the effects of legislative smoking bans on second-hand smoke exposure. Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev. 2010;14(4):CD005992. doi:10.​1002/​14651858.​CD005992.​pub2. This is a general review of the effects of legislative smoking bans on second-hand smoke exposure.
33.
go back to reference WHO Framework Convention on Tobacco Control: Guidelines for Implementation 2009; 24–30. WHO Framework Convention on Tobacco Control: Guidelines for Implementation 2009; 24–30.
34.
go back to reference Sims M et al. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ. 2010;340:c2161.PubMedCrossRefPubMedCentral Sims M et al. Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ. 2010;340:c2161.PubMedCrossRefPubMedCentral
35.•
go back to reference Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national irish smoking ban: interrupted time-series analysis. PLoS One. 2013;8(4):e62063. This is one of the first studies evaluating the impact of an effective national program to reduce tobacco-related mortality.PubMedCrossRefPubMedCentral Stallings-Smith S, Zeka A, Goodman P, Kabir Z, Clancy L. Reductions in cardiovascular, cerebrovascular, and respiratory mortality following the national irish smoking ban: interrupted time-series analysis. PLoS One. 2013;8(4):e62063. This is one of the first studies evaluating the impact of an effective national program to reduce tobacco-related mortality.PubMedCrossRefPubMedCentral
Metadata
Title
Second-hand Smoking and CV Risk
Authors
Ioana Munteanu, MD
Florin Dumitru Mihălţan, MD
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 12/2014
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-014-0348-8

Other articles of this Issue 12/2014

Current Treatment Options in Cardiovascular Medicine 12/2014 Go to the issue

Prevention (L Sperling and D Gaita, Section Editors)

Renal Denervation Therapy for Resistant Hypertension

Prevention (L Sperling and D Gaita, Section Editors)

Medication Adherence in Secondary Prevention Post-Myocardial Infarction

Pediatric Congenital Heart Disease (G Singh, Section Editor)

Childhood Obesity and Insulin Resistance: How Should It Be Managed?